213 related articles for article (PubMed ID: 2404751)
1. Multihormonal regulation of the progesterone receptor in MCF-7 human breast cancer cells: interrelationships among insulin/insulin-like growth factor-I, serum, and estrogen.
Katzenellenbogen BS; Norman MJ
Endocrinology; 1990 Feb; 126(2):891-8. PubMed ID: 2404751
[TBL] [Abstract][Full Text] [Related]
2. Regulation of progesterone receptor gene expression in MCF-7 breast cancer cells: a comparison of the effects of cyclic adenosine 3',5'-monophosphate, estradiol, insulin-like growth factor-I, and serum factors.
Cho H; Aronica SM; Katzenellenbogen BS
Endocrinology; 1994 Feb; 134(2):658-64. PubMed ID: 7507831
[TBL] [Abstract][Full Text] [Related]
3. Regulation of estrogen receptor messenger ribonucleic acid and protein levels in human breast cancer cell lines by sex steroid hormones, their antagonists, and growth factors.
Read LD; Greene GL; Katzenellenbogen BS
Mol Endocrinol; 1989 Feb; 3(2):295-304. PubMed ID: 2785242
[TBL] [Abstract][Full Text] [Related]
4. Progesterone receptor regulation in uterine cells: stimulation by estrogen, cyclic adenosine 3',5'-monophosphate, and insulin-like growth factor I and suppression by antiestrogens and protein kinase inhibitors.
Aronica SM; Katzenellenbogen BS
Endocrinology; 1991 Apr; 128(4):2045-52. PubMed ID: 1706263
[TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor-I inhibits progesterone receptor expression in breast cancer cells via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway: progesterone receptor as a potential indicator of growth factor activity in breast cancer.
Cui X; Zhang P; Deng W; Oesterreich S; Lu Y; Mills GB; Lee AV
Mol Endocrinol; 2003 Apr; 17(4):575-88. PubMed ID: 12554765
[TBL] [Abstract][Full Text] [Related]
6. Differential responsiveness of human breast cancer cell lines MCF-7 and T47D to growth factors and 17 beta-estradiol.
Karey KP; Sirbasku DA
Cancer Res; 1988 Jul; 48(14):4083-92. PubMed ID: 3289739
[TBL] [Abstract][Full Text] [Related]
7. Proliferation, hormonal responsiveness, and estrogen receptor content of MCF-7 human breast cancer cells grown in the short-term and long-term absence of estrogens.
Katzenellenbogen BS; Kendra KL; Norman MJ; Berthois Y
Cancer Res; 1987 Aug; 47(16):4355-60. PubMed ID: 3607768
[TBL] [Abstract][Full Text] [Related]
8. Progesterone crosstalks with insulin-like growth factor signaling in breast cancer cells via induction of insulin receptor substrate-2.
Cui X; Lazard Z; Zhang P; Hopp TA; Lee AV
Oncogene; 2003 Oct; 22(44):6937-41. PubMed ID: 14534541
[TBL] [Abstract][Full Text] [Related]
9. Laminin inhibits estrogen action in human breast cancer cells.
Woodward TL; Lu H; Haslam SZ
Endocrinology; 2000 Aug; 141(8):2814-21. PubMed ID: 10919267
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor-II (IGF-II): a potential autocrine/paracrine growth factor for human breast cancer acting via the IGF-I receptor.
Osborne CK; Coronado EB; Kitten LJ; Arteaga CI; Fuqua SA; Ramasharma K; Marshall M; Li CH
Mol Endocrinol; 1989 Nov; 3(11):1701-9. PubMed ID: 2558302
[TBL] [Abstract][Full Text] [Related]
11. The antiprogestin RU38 486: receptor-mediated progestin versus antiprogestin actions screened in estrogen-insensitive T47Dco human breast cancer cells.
Horwitz KB
Endocrinology; 1985 Jun; 116(6):2236-45. PubMed ID: 4039656
[TBL] [Abstract][Full Text] [Related]
12. Paradoxical effects of overexpression of the type I insulin-like growth factor (IGF) receptor on the responsiveness of human breast cancer cells to IGFs and estradiol.
Daws MR; Westley BR; May FE
Endocrinology; 1996 Apr; 137(4):1177-86. PubMed ID: 8625887
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factors modulate the growth inhibitory effects of retinoic acid on MCF-7 breast cancer cells.
Bentel JM; Lebwohl DE; Cullen KJ; Rubin MS; Rosen N; Mendelsohn J; Miller WH
J Cell Physiol; 1995 Oct; 165(1):212-21. PubMed ID: 7559803
[TBL] [Abstract][Full Text] [Related]
14. The effects of insulin and insulin-like growth factors-I and -II on estradiol production by granulosa cells of polycystic ovaries.
Erickson GF; Magoffin DA; Cragun JR; Chang RJ
J Clin Endocrinol Metab; 1990 Apr; 70(4):894-902. PubMed ID: 2108185
[TBL] [Abstract][Full Text] [Related]
15. Factors controlling proliferation and progesterone production by bovine granulosa cells in serum-free medium.
Savion N; Lui GM; Laherty R; Gospodarowicz D
Endocrinology; 1981 Aug; 109(2):409-20. PubMed ID: 6454570
[TBL] [Abstract][Full Text] [Related]
16. Effect of progestin treatment on estradiol-and growth factor-stimulated breast cancer cell lines.
Cappelletti V; Miodini P; Fioravanti L; Di Fronzo G
Anticancer Res; 1995; 15(6B):2551-5. PubMed ID: 8669822
[TBL] [Abstract][Full Text] [Related]
17. Keratinocyte growth factor (KGF) induces tamoxifen (Tam) resistance in human breast cancer MCF-7 cells.
Chang HL; Sugimoto Y; Liu S; Ye W; Wang LS; Huang YW; Lin YC
Anticancer Res; 2006; 26(3A):1773-84. PubMed ID: 16827106
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor-I (IGF-I) and IGF-II hormonal action in cultured rat granulosa cells: mediation via type I but not type II IGF receptors.
Adashi EY; Resnick CE; Rosenfeld RG
Endocrinology; 1990 Jan; 126(1):216-22. PubMed ID: 2152863
[TBL] [Abstract][Full Text] [Related]
19. Role of the insulin-like growth factor system on an estrogen-dependent cancer phenotype in the MCF-7 human breast cancer cell line.
Bradley LM; Gierthy JF; Pentecost BT
J Steroid Biochem Mol Biol; 2008 Mar; 109(1-2):185-96. PubMed ID: 18337089
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor binding proteins-2 and -3 stimulate growth hormone receptor binding and mitogenesis in rat osteosarcoma cells.
Slootweg MC; Ohlsson C; Salles JP; de Vries CP; Netelenbos JC
Endocrinology; 1995 Oct; 136(10):4210-7. PubMed ID: 7545101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
